Document is current
Any future updates will be listed below
-
Authors
Huang, Yi-Wei https://orcid.org/0000-0001-7127-4242
Tsai, Tsen-Fang https://orcid.org/0000-0002-1498-1474
- License Information
-
More Information
Article History
Accepted: 27 December 2020
First Online: 18 January 2021
Declarations
:
: No funding was received for the preparation of this article.
: Yi-Wei Huang has no conflicts of interest that are directly relevant to the content of this article. Tsen-Fang Tsai has conducted clinical trials or received honoraria for serving as a consultant for Abbvie, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Eli Lilly, Galderma, Janssen-Cilag, Merck Sharp & Dohme, Novartis International AG, Pfizer Inc., and UCB Pharma.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: All authors contributed to the study conception and design. The literature search and data analysis were performed by Yi-Wei Huang and Tsen-Fang Tsai. The first draft of the manuscript was written by Yi-Wei Huang and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
